Anna van Veelen, Casper F Coerkamp, Yvemarie B O Somsen, Truls Råmunddal, Dan Ioanes, Peep Laanmets, René J van der Schaaf, Erlend Eriksen, Matthijs Bax, Maarten Jan Suttorp, Bradley H Strauss, Emanuele Barbato, Koen M Marques, Martijn Meuwissen, Olivier Bertrand, Martin van der Ent, Paul Knaapen, Jan G P Tijssen, Bimmer E P M Claessen, Loes P C Hoebers, Joëlle Elias, José P S Henriques
BACKGROUND: The EXPLORE (Evaluating Xience and Left Ventricular Function in PCI on Occlusions After STEMI) trial was the first and only randomized trial investigating chronic total occlusion (CTO) percutaneous coronary intervention (PCI) early after primary PCI for ST-segment-elevation myocardial infarction, compared with medical therapy for the CTO. We performed a 10-year follow-up of EXPLORE to investigate long-term safety and clinical impact of CTO PCI after ST-segment-elevation myocardial infarction, compared with no-CTO PCI...
May 10, 2024: Journal of the American Heart Association